Firms
Theme

GEN

Gen Digital Inc. · NASDAQ

News

8 latest

Zacks Investment Research

GEN or TT: Which Is the Better Value Stock Right Now?

A comparison of Gen Digital (GEN) and Trane Technologies (TT) for value investors reveals that GEN is the more attractive option. GEN has a Zacks Rank of #2 (Buy) with a Value grade of A, supported by a lower forward P/E of 8.50 and PEG ratio of 0.71. TT has a Zacks Rank of #3 (Hold) with a Value grade of D, featuring a higher forward P/E of 29.30 and PEG ratio of 2.09.

Zacks Investment Research

GEN or TT: Which Is the Better Value Stock Right Now?

A comparison of Gen Digital (GEN) and Trane Technologies (TT) reveals that GEN presents a better value opportunity for investors. GEN has a Zacks Rank of #2 (Buy) with a forward P/E of 7.79 and Value grade of A, while TT has a Zacks Rank of #3 (Hold) with a forward P/E of 31.13 and Value grade of D. GEN's stronger estimate revision activity and more attractive valuation metrics make it the superior choice for value investors.

Zacks Investment Research

Here's Why Gen Digital (GEN) is a Strong Value Stock

Zacks Premium offers Style Scores (Value, Growth, Momentum, and VGM) that complement the Zacks Rank system to help investors identify stocks with the best performance potential. The Zacks Rank #1 stocks have averaged +23.86% annual returns since 1988, more than double the S&P 500. Gen Digital (GEN) is highlighted as a Stock to Watch with a #2 Buy rank and strong Value and VGM Style Scores.

Zacks Investment Research

Gen Digital (GEN) Loses 32.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Gen Digital stock has declined 32.7% over the past four weeks and is now in oversold territory with an RSI reading of 18.75, suggesting potential for a trend reversal. Despite the sharp decline, Wall Street analysts have raised earnings estimates by 0.8% over the last 30 days, and the stock holds a Zacks Rank #2 (Buy) rating, indicating strong potential for near-term price recovery.

Mentions GEN

Zacks Investment Research

Here's Why Investors Should Hold MAN Stock in Their Portfolios Now

ManpowerGroup (MAN) is experiencing growth fueled by strong Americas and Southern Europe revenues, with cost optimization targeting $200M in annual savings by 2028 and AI adoption expected to boost operating efficiency. However, the company faces headwinds from intense staffing market competition, AI-driven automation threats, and declining cash reserves that limit financial flexibility.

Zacks Investment Research

Reasons Why Investors Can Consider Buying Clean Harbors Stock Now

Clean Harbors (CLH) has outperformed its industry with a 5.6% gain over three months and is projected to achieve 7.8% revenue growth and 34.3% earnings growth in 2026. The company's recent acquisitions of Terra Nova Solutions, EnviroServe, and ES&H are expected to add $340 million in annual revenues and $87 million in adjusted EBITDA, while improving profitability metrics and cash flow generation support continued shareholder returns.

Zacks Investment Research

NSP Stock Surges 78.1% in 6 Months: Here's What You Should Know

Insperity (NSP) shares have surged 78.1% over six months, significantly outperforming the industry's 46.6% growth. The company's HRScale platform has expanded to nearly 8,000 worksite employees in sold accounts, providing a new growth avenue. NSP also demonstrated cost discipline with an 8% year-over-year reduction in operating expenses while maintaining a consistent 60-cent quarterly dividend and strong liquidity position.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $GEN · 0 threads

Sign in to post on $GEN

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev